Marek Kovář - Concepedia

Author

Marek Kovář

Czech Academy of Sciences, Institute of Microbiology ORCID

Also Known As

Kovar Marek, M Kovar, M Kovář, M. Kovar, M. Kovář, Marek Kovar, Marek KovÁŘ, Marek Kovár, Marek Kovář

113

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Czech Academy of Sciences, Institute of Microbiology Czech Academy of Sciences Czech Academy of Sciences, Institute of Macromolecular Chemistry Charles University Sotio (Czechia)

About

Marek Kovář is an author at Czech Academy of Sciences, Institute of Microbiology specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	2.3K
2	Engineering	6	6	200
3	Allergy	2	2	1.3K
4	Health Sciences	1	1	98
5	Natural Sciences	1	1	26

Marek Kovář

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes Onur Boyman, Marek Kovář, Mark P. Rubinstein, Science Adaptive Immune SystemT-regulatory CellImmunologyImmunologic MechanismAntigen Processing	2006	860
Converting IL-15 to a superagonist by binding to soluble IL-15Rα Mark P. Rubinstein, Marek Kovář, Jared F. Purton, Proceedings of the National Academy of Sciences InflammationCytokineMolecular ImmunologySoluble Il-15Allergy	2006	403
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms Jamie B. Spangler, Jakub Tomala, Vincent C. Luca, Immunity InflammationDistinct Conformational MechanismsAutoimmune DiseaseAdaptive Immune SystemT-regulatory Cell	2015	214
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes B Řı́hová, Tomáš Etrych, Michal Pechar, Journal of Controlled Release Polymer-drug ConjugateMedicineHydrazone BondCancer BiologyDoxorubicin Bound	2001	103
In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy Jakub Tomala, Helena Chmelova, Tomáš Mrkvan, The Journal of Immunology ImmunologyImmunoeditingAnti-il-2 Monoclonal AntibodyImmunologic MechanismCd4 T Cell Responses	2009	100
The Inner Ear in Diabetes Mellitus Marek Kovář ORL Serial SectionsHealth SciencesDiabetesAudiologyPhysiology	1973	98
Star Structure of Antibody-Targeted HPMA Copolymer-Bound Doxorubicin: A Novel Type of Polymeric Conjugate for Targeted Drug Delivery with Potent Antitumor Effect Marek Kovář, J. Strohalm, Tomáš Etrych, Bioconjugate Chemistry	2002	70
Biological Evaluation of Polymeric Micelles with Covalently Bound Doxorubicin David Větvička, Martin Hrubý, Ondřej Hovorka, Bioconjugate Chemistry	2009	69
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer Lenka Kašíková, Jana Raková, Michal Hensler, Nature Communications	2024	69
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy Jamie B. Spangler, Eleonora Trotta, Jakub Tomala, The Journal of Immunology	2018	66

Page 1